Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

RIFAMPIN for Injection

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-340-31 D-0416-2015
Class II · Moderate risk

Colistimethate for Injection USP

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-193-31 D-0415-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-672-10 D-0399-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-659-05 D-0398-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing.

Terminated Impurity / degradation West-Ward Pharmaceutical Corporation NDC 0641-6028-25 D-0420-2015
Class II · Moderate risk

Phen 15 mg - Topri 92 mg SR Cap

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D1051-2015
Class II · Moderate risk

Hydrocortisone 1.6 mg/0.5 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1062-2015
Class II · Moderate risk

Nystatin 50

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1061-2015
Class II · Moderate risk

Coconut Oil Suppository

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1060-2015
Class II · Moderate risk

Cyclandelate 200 mg Caps

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1059-2015
Class II · Moderate risk

Triest 5 mg - Progest 150 mg Capsule

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1058-2015
Class II · Moderate risk

Colchicine 0.6 mg Caps

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1057-2015
Class II · Moderate risk

Lansoprazole 3 mg/mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1056-2015
Class II · Moderate risk

Thymol 2% Solution

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1055-2015
Class II · Moderate risk

Methenamine/Phenyl Salicylate Capsule

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1054-2015

Recalls by year